Abbott Laboratories (FRA:ABL)
110.22
+0.40 (0.36%)
Last updated: Aug 14, 2025
Abbott Laboratories Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 195,827 | 189,494 | 172,877 | 179,118 | 212,232 | 153,363 | Upgrade
|
Market Cap Growth | 19.43% | 9.61% | -3.48% | -15.60% | 38.39% | 12.04% | Upgrade
|
Enterprise Value | 201,337 | 196,729 | 180,897 | 185,558 | 220,076 | 164,842 | Upgrade
|
Last Close Price | 110.96 | 108.39 | 96.29 | 97.44 | 117.12 | 81.46 | Upgrade
|
PE Ratio | 16.51 | 14.69 | 33.52 | 27.72 | 34.28 | 41.94 | Upgrade
|
PS Ratio | 5.33 | 4.68 | 4.76 | 4.39 | 5.60 | 5.42 | Upgrade
|
PB Ratio | 4.52 | 4.10 | 4.92 | 5.19 | 6.70 | 5.68 | Upgrade
|
P/TBV Ratio | 11.11 | 10.96 | 31.28 | 55.76 | - | - | Upgrade
|
P/FCF Ratio | - | 30.89 | 37.77 | 24.53 | 27.91 | 32.77 | Upgrade
|
P/OCF Ratio | - | 22.92 | 26.32 | 19.98 | 22.92 | 23.74 | Upgrade
|
EV/Sales Ratio | 5.47 | 4.86 | 4.99 | 4.54 | 5.81 | 5.83 | Upgrade
|
EV/EBITDA Ratio | 19.95 | 19.01 | 19.11 | 16.02 | 19.64 | 22.94 | Upgrade
|
EV/EBIT Ratio | 28.36 | 27.17 | 27.69 | 21.76 | 27.19 | 36.92 | Upgrade
|
EV/FCF Ratio | 34.90 | 32.07 | 39.52 | 25.41 | 28.94 | 35.23 | Upgrade
|
Debt / Equity Ratio | 0.27 | 0.32 | 0.41 | 0.49 | 0.53 | 0.60 | Upgrade
|
Debt / EBITDA Ratio | 1.14 | 1.38 | 1.47 | 1.41 | 1.47 | 2.18 | Upgrade
|
Debt / FCF Ratio | 1.99 | 2.40 | 3.14 | 2.30 | 2.23 | 3.48 | Upgrade
|
Asset Turnover | 0.55 | 0.54 | 0.54 | 0.58 | 0.58 | 0.49 | Upgrade
|
Inventory Turnover | 2.74 | 2.92 | 2.81 | 3.37 | 3.56 | 3.22 | Upgrade
|
Quick Ratio | 1.14 | 1.05 | 1.00 | 1.06 | 1.28 | 1.14 | Upgrade
|
Current Ratio | 1.82 | 1.67 | 1.64 | 1.63 | 1.85 | 1.72 | Upgrade
|
Return on Equity (ROE) | 30.93% | 30.91% | 15.11% | 19.01% | 20.49% | 13.91% | Upgrade
|
Return on Assets (ROA) | 6.62% | 6.06% | 6.11% | 7.61% | 7.79% | 4.86% | Upgrade
|
Return on Capital (ROIC) | 8.75% | 7.95% | 8.24% | 10.34% | 10.64% | 6.61% | Upgrade
|
Return on Capital Employed (ROCE) | 11.80% | 11.10% | 12.20% | 15.50% | 14.80% | 9.00% | Upgrade
|
Earnings Yield | 6.06% | 6.83% | 3.00% | 3.62% | 2.93% | 2.40% | Upgrade
|
FCF Yield | 2.95% | 3.24% | 2.65% | 4.08% | 3.58% | 3.05% | Upgrade
|
Dividend Yield | 1.91% | 2.00% | 1.95% | 1.84% | 1.37% | 1.54% | Upgrade
|
Payout Ratio | 28.42% | 28.62% | 62.13% | 47.73% | 45.28% | 56.95% | Upgrade
|
Buyback Yield / Dilution | 0.08% | 0.06% | 0.85% | 1.40% | -0.17% | -0.28% | Upgrade
|
Total Shareholder Return | 1.98% | 2.05% | 2.80% | 3.24% | 1.20% | 1.25% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.